ITM, Navigo collaborate on radioisotope
December 3, 2021 -- German radiopharmaceutical firm ITM Isotope Technologies Munich and Navigo Proteins are teaming up to develop a fibroblast activation protein-targeted radiopharmaceutical program for the treatment of solid tumors. Read More
Mirion closes $54M CIRS acquisition
December 2, 2021 -- Radiation monitoring firm Mirion Technologies has completed its previously announced acquisition of Computerized Imaging Reference Systems (CIRS) in a deal worth about $54 million. Read More
RefleXion guided lung radiotherapy designated 'breakthrough'
December 1, 2021 -- RefleXion Medical's biology-guided radiotherapy has received a breakthrough device designation from the U.S. Food and Drug Administration for use in treating lung tumors. Read More
Monrol and MTTI ink Lu-177 supply deal
November 19, 2021 -- EczacıbaŞı-Monrol Nuclear Products has signed an agreement to supply Molecular Targeting Technologies (MTTI) with no-carrier-added lutetium-177 (Lu-177). Read More
NorthStar to buy accelerator for actinium-225 production
November 18, 2021 -- NorthStar Medical Radioisotopes has inked a deal with Ion Beam Applications (IBA) to purchase one of IBA's Rhodotron TT300 HE electron-beam accelerators for the commercial production of actinium-225 (Ac-225) at its new production facility in Beloit, WI. Read More
MIM gets FDA nod for molecular radiotherapy software
November 17, 2021 -- Medical imaging software developer MIM software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SurePlan MRT molecular radiotherapy software. Read More
Mirion to acquire CIRS in $54M deal
November 12, 2021 -- Mirion Technologies recently signed an agreement to acquire Computerized Imaging Reference Systems (CIRS), a provider of imaging and radiation therapy phantoms, in a deal worth about $54 million. Read More
Clarity hits milestone in study of radiopharmaceutical
November 12, 2021 -- Clarity Pharmaceuticals, the Australian-based radiopharmaceutical developer, has completed patient recruitment in the dosimetry phase of a study of its theranostic agent with copper-based radioisotopes for treating metastatic castration-resistant prostate cancer. Read More
ANSTO to partner with Cyclotek on theranostics facility
November 12, 2021 -- The Australian Nuclear Science and Technology Organisation (ANSTO) is entering into a joint venture with Cyclotek to build a new theranostics facility in Melbourne. Read More
Nvidia unveils new healthcare offerings at GTC Fall 2021
November 9, 2021 -- Graphics processing unit technology developer Nvidia is introducing a new healthcare artificial intelligence computing platform, as well as a new relationship with MD Anderson Cancer Center, at this week's GPU Technology Conference (GTC) Fall 2021. Read More
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT